Immix Biopharma, Inc. - Common Stock (IMMX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2021 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
IMMX on Nasdaq
Shares outstanding
52,992,611
Price per share
$4.87
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
24,382,712
Total reported value
$127,497,003
% of total 13F portfolios
0%
Share change
+21,359,135
Value change
+$111,804,992
Number of holders
67
Price from insider filings
$4.87
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Immix Biopharma, Inc. - Common Stock (IMMX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 7.4% $19,098,036 3,921,568 JANUS HENDERSON GROUP PLC 31 Dec 2025
Saturn V Capital Management LP 7% $17,987,759 3,693,585 Saturn V Capital Management LP 26 Dec 2025

As of 31 Dec 2025, 67 institutional investors reported holding 24,382,712 shares of Immix Biopharma, Inc. - Common Stock (IMMX). This represents 46% of the company’s total 52,992,611 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Immix Biopharma, Inc. - Common Stock (IMMX) together control 43% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
JANUS HENDERSON GROUP PLC 7.4% 3,921,568 0.01% $20,470,585
Saturn V Capital Management LP 5.7% 2,999,169 2.9% $15,685,654
EVENTIDE ASSET MANAGEMENT, LLC 4.8% 2,549,019 0.21% $13,331,369
MARSHALL WACE, LLP 3.7% 1,978,743 +3495% 0.01% $10,348,824
MILLENNIUM MANAGEMENT LLC 3.1% 1,659,778 0.01% $8,680,639
ADAGE CAPITAL PARTNERS GP, L.L.C. 2.8% 1,500,000 0.01% $7,845,000
VANGUARD GROUP INC 2.1% 1,095,814 +50% 0% $5,731,107
Logos Global Management LP 1.9% 1,000,000 0.35% $5,230,000
Bleichroeder LP 1.9% 1,000,000 +18% 0.92% $5,230,000
Blue Owl Capital Holdings LP 1.9% 986,240 1.6% $5,158,035
FRANKLIN RESOURCES INC 1.9% 980,392 0% $5,127,450
AMERIPRISE FINANCIAL INC 0.85% 452,147 0% $2,364,729
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.74% 393,887 +334% 0% $2,060,029
PERCEPTIVE ADVISORS LLC 0.64% 338,941 0.03% $1,772,661
BURKEHILL GLOBAL MANAGEMENT, LP 0.56% 294,118 0.1% $1,538,237
RENAISSANCE TECHNOLOGIES LLC 0.49% 258,600 +1103% 0% $1,352,478
GEODE CAPITAL MANAGEMENT, LLC 0.46% 246,056 +31% 0% $1,287,519
KVP Capital Advisors, LP 0.43% 230,423 0% 1.2% $1,205,112
GOLDMAN SACHS GROUP INC 0.39% 208,370 0% $1,089,775
JANE STREET GROUP, LLC 0.32% 167,132 +1016% 0% $874,101
BlackRock, Inc. 0.25% 130,255 +202% 0% $681,233
MORGAN STANLEY 0.24% 126,622 +4.9% 0% $662,232
LGT Fund Management Co Ltd. 0.24% 125,000 0.05% $660,000
Informed Momentum Co LLC 0.23% 120,856 0.07% $632,077
J. Goldman & Co LP 0.22% 118,261 0.02% $618,505

Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 24,382,712 $127,497,003 +$111,804,992 $5.23 67
2025 Q3 2,765,928 $5,781,309 +$912,474 $2.09 31
2025 Q2 2,262,228 $4,682,595 -$1,044,152 $2.07 23
2025 Q1 2,918,442 $4,902,496 +$70,569 $1.68 22
2024 Q4 2,870,949 $6,315,600 -$1,857,745 $2.20 22
2024 Q3 4,094,667 $6,102,781 -$618,016 $1.49 25
2024 Q2 4,429,414 $8,774,511 -$597,024 $1.98 29
2024 Q1 5,090,000 $15,715,858 +$12,671,335 $3.07 34
2023 Q4 783,068 $5,326,329 +$2,756,459 $6.92 28
2023 Q3 405,051 $1,385,659 -$652,595 $3.42 16
2023 Q2 633,819 $1,705,059 +$653,633 $2.69 17
2023 Q1 400,796 $729,846 -$97,971 $1.82 12
2022 Q4 440,750 $1,011,250 +$306,049 $2.29 18
2022 Q3 298,959 $406,000 +$156,569 $1.36 7
2022 Q2 183,385 $475,000 +$120,000 $2.59 6
2022 Q1 146,485 $352,000 -$5,019,402 $2.39 7
2021 Q4 1,538,439 $5,473,200 +$3,457,200 $3.56 11